#Medtech

In a groundbreaking research effort that could transform the lives of millions, scientists have unveiled a potential cure for type 1 diabetes and other debilitating autoimmune diseases through a novel protein-based therapy, according to a new international study published in the journal Cell (nyulangone.org). The collaborative research, spearheaded by NYU Langone Health, the Chinese Academy of Sciences, and Zhejiang University, demonstrates for the first time how targeted suppression of misbehaving immune cells in animal models may fully halt disease progression—pointing toward a future in which permanent relief from diseases like diabetes, multiple sclerosis (MS), and autoimmune hepatitis could be within reach.